ArticleTranslational oncology2026

AVIL promotes osteosarcoma progression and cisplatin resistance via ARP2/3-mediated DNA damage repair.

Zhenyi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.